"Elraglusib with chemotherapy and immune priming represents a novel sequential therapy approach to treat advanced salivary cancers ... enhancer of activated B cells (NF-kB) and DNA Damage Response ...

Actuate Therapeutics, Inc. announced that data on their investigational drug elraglusib, designed to treat advanced salivary gland carcinoma ... and enhancing immune cell function in cancer ...

A sore throat or hoarseness that won’t improve could be more serious, according to Dr. Charles Johnson Jr., an ear, nose and throat (ENT) and head and neck surgeon. He ...

It is also known that salivary gland epithelial cells (SGEC) play a pathogenic role in Sjögren's disease. Two abstracts presented at the 2024 congress of EULAR—The European Alliance of ...

IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory condition marked by the accumulation of IgG4-positive plasma ...

You also have one parotid gland on each side ... uses high-energy X-rays to destroy cancer cells. Here are a few ways your doctor uses EBRT: Three-dimensional conformal radiation therapy uses ...

“Elraglusib with chemotherapy and immune priming represents a novel sequential therapy approach to treat advanced salivary cancers ... nuclear factor kappa-light-chain-enhancer of activated B cells ...

Often harmless, sometimes a sign of illness: what causes halitosis and what can you do to keep your breath fresh?

Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted full approval for VITRAKVI® (larotrectinib), a first-in-class TRK inhibitor for the treatment of adult and pediatric ...

Skin cancers such as squamous cell carcinoma and melanoma can metastasize to lymph nodes in and near the bilateral parotid glands, and thus mimic a primary parotid tumor. Most salivary gland cancers ...